The DOI matches its Crossref record; the references it cites are not checked yet.
Pharmacotherapy of anxiety disorders: a critical review
Open accessAbstract
Given the enormous contribution of anxiety disorders to the burden of disease, it is key to optimize their prevention and treatment. In this critical review we assess advances in the pharmacotherapy of anxiety disorders, as well as remaining challenges, in recent decades, the field has seen rigorous clinical trial methods to quantify the efficacy and safety of serendipitously discovered agents, more focused development of medications with selective mechanisms of action, and the gradual translation of insights from laboratory research into proof-of-principle clinical trials. On the positive side, a considerable database of studies shows efficacy and relative tolerability of the selective serotonin reuptake inhibitors in the major anxiety disorders, and secondary analyses of such datasets have informed questions such as optimal definition of response and remission, optimal dose and duration, and comparative efficacy of different agents. Significant challenges in the field include barriers to appropriate diagnosis and treatment of anxiety disorders, failure of a significant proportion of patients to respond to first-line pharmacotherapy agents, and a limited database of efficacy or effectiveness studies to guide treatment in such cases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cognitive-behavioral therapy (CBT) and selective serotonin reuptake inhibitors (SSRIs) are effective treatments for anxiety disorders (Hoffman & Smits, 2008; Koen & Stein, 2011).”
From Treatment gap for anxiety disorders is global: Results of the World Mental Health Surveys in 21 countries (2018) · cites this paper as Koen & Stein, 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“response rates to anti-anxiety medications vary from 30 to 68%7”
From Cluster-based psychological phenotyping and differences in anxiety treatment outcomes (2023) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Individuals with anxiety disorders, such as generalized anxiety disorder (GAD), display varying responses to pharmacological agents and psychotherapeutic approaches: response rates to anti-anxiety medications vary from 30 to 68%7, while 46% of patients showed clinical improvement from psychotherapeutic treatment8.”
From Cluster-based psychological phenotyping and differences in anxiety treatment outcomes (2023) · cites this paper as [7]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Even though several pharmacological treatments exist, they are sometimes ineffective and associated with harmful iatrogenic effects15,16.”
From Benefits from one session of deep and slow breathing on vagal tone and anxiety in young and older adults (2021) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 175 · Cited by 151
Research works printed but not linked: 35
- Kapczinski F., 2003, Cochrane Database Syst Rev., 003592
- Baldwin D., 2011, BMJ., 324, 1
- Ballenger JC., 2001, J Clin Psychiatry., 62, 53
- Hoehn-Saric R., 1988, J Clin Psychiatry., 49, 293
- Chessick CA., 2006, Cochrane Database Syst Rev., 3, CD006115
- Coplan JD., 1993, J Clin Psychiatry., 54, 69
- Depping AM., 2010, Cochrane Database Syst Rev., 12, CD008120
- National Institute for Clinical Excellence (NICE)., 2004, The Management of Panic Disorder and Generalised Anxiety Disorder in Primary and Secondary Care. London, UK: National Collaborating Centre for Mental Health.
- Soomro GM., 2008, Cochrane Database Syst Rev., 23, CD001765
- Denys D., 2004, J Clin Psychiatry., 65, 11
- Joel D., 2008, Animal and Translational Models for CNS Drug Discovery., 33
- Koran LM., 2007, Am J Psychiatry., 164, 5
- Pallanti S., 2002, Int Clin Psychopharmacol., 5, 181
- Ipser JC., 2006, Cochrane Database Syst Rev., 005473
- Coric V., 2006, Experimental NeuroTherapeutics., 3, 69, 10.1016/j.nurx.2005.12.006 · DOI · Paper page
- Deveney CM., 2009, Clin Neuropsychiatry., 6, 75
- Royal College of Psychiatrists., 2000, Neurosurgery for mental disorder. Report from the Neurosurgery Working Group of the Royal College of Psychiatrists., 89
- Noyes R., 1989, J Clin Psychiatry., 50, 163
- Seedat S., 2003, Int Clin Psychopharmacol., 18, 279
- Woodman CL., 1994, J Clin Psychiatry., 55, 134
- Mathew SJ., 2001, Psychopharmacol Bull., 35, 97
- Pollack MH., 1994, J Clin Psychiatry., 55, 200
- Stein DJ., 2009, CNS Spectr., 14, 25
- Davidson JRT., 2004, J Neuropsychiatry Clin Neurosci., 16, 135, 10.1176/jnp.16.2.135 · doi:10.1176/jnp.16.2.135 · Paper page
- Falcon S., 1985, J Clin Psychiatry., 46, 385
- National Institute for Clinical Excellence (NICE)., Post-traumatic stress disorder. The management of PTSD in adults and children in primary and secondary care. National Clinical Practice Guideline number 26. London, UK: The Royal College of Psychiatrists and the British Psychological Society 2005.
- Stein DJ., 2009, CNS Spectr., 41, 52
- Ballenger JC., 2000, J Clin Psychiatry., 61, 60
- Foa EB., 1999, J Clin Psychiatry., 60, 1
- Hamner MB., 2003, Int Clin Psychopharmacol., 18, 1
- Stein DJ., 2004, Cochrane Database Syst Rev., 4, CD001206
- Seedat S., 2004, J Clin Psychiatry., 65, 244
- Warwick JM., 2006, Metab Brain Dis.
- Ipser JC., 2009, Cochrane Database Syst Rev., 005170
- Davidson JRT., 2004, Anxiety., 19, 234
Metadata
- Authors
- Koen, N., & Stein, D. J.
- Affiliations
- University of Cape Town (ZA)
- Corresponding author
- Stein, Dan J.
- Venue
- Dialogues in Clinical Neuroscience
- Publisher
- Informa UK Limited
- Published
- 2011-12-31
- Volume
- 13
- Issue
- 4
- Pages
- 423-437
- ISSN
- 1294-8322 (ISSN-L)
- 1958-5969
- PMC
- PMC3263390
- OpenAlex
- W4360754754
- Semantic Scholar
- a11750262321cd0ca6b38cb87d9101b49ba8efa6
- Cited by
- 151
- References
- 175
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 9 · 2023: 11 · 2022: 8 · 2021: 7 · 2020: 12 · 2019: 13 · 2018: 10 · 2017: 7 · 2016: 11 · 2015: 9 · 2014: 18 · 2013: 18 · 2012: 4
- FWCI
- 16.33
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- Locations
- Dialogues in Clinical Neuroscience (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- SUNScholar (Stellenbosch University) (submittedVersion)
- PubMed
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
- Keywords
- anxiety disorders, pharmacotherapy, selective serotonin reuptake inhibitors, treatment-resistant anxiety, treatment response and remission, drug safety and tolerability
- MeSH terms
- Anxiety Disorders, Humans, Anti-Anxiety Agents, Selective Serotonin Reuptake Inhibitors, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacotherapy of anxiety disorders: a critical review. https://app.cochat.ai/papers/10.31887/dcns.2011.13.4/nkoen
- The paper
- Koen, N., & Stein, D. J. (2011). Pharmacotherapy of anxiety disorders: a critical review. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2011.13.4/nkoen
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.